Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Oncotargets and Therapy
|
November 25, 2020
Clinical Characteristics and Prognosis of Gastric Cancer Patients with <i>BRCA 1/2</i> Germline Mutations: Report of Ten Cases and a Literature Review
Naama Halpern, Albert Grinshpun, Ben Boursi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients
Baruch Brenner, Ravit Geva, Megan Rothney, et al.
The American Journal of Surgical Pathology
|
March 25, 2008
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia, Laura H Tang, Martin R Weiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2020
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD
Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, et al.
Targeted Oncology
|
January 22, 2018
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
Ofer Purim, Alexander Beny, Moshe Inbar, et al.
The Oncologist
|
September 8, 2018
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, et al.
Cancer Research
|
February 6, 2021
Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles
Nil Grunberg, Meirav Pevsner-Fischer, Tal Goshen-Lago, et al.
JAMA Network Open
|
October 19, 2020
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial
Benoist Chibaudel, Julie Henriques, Manel Rakez, et al.
Nature Cancer
|
February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Nancy Gavert, Yaara Zwang, Roi Weiser, et al.
Frontiers in Pharmacology
|
May 6, 2026
Favorable safety outcomes of a perioperative propranolol and etodolac regimen in cancer patients in four randomized controlled trials
Nahida Sakis, Liat Sorski, Eden Asraf, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Oncotargets and Therapy
|
November 25, 2020
Clinical Characteristics and Prognosis of Gastric Cancer Patients with <i>BRCA 1/2</i> Germline Mutations: Report of Ten Cases and a Literature Review
Naama Halpern, Albert Grinshpun, Ben Boursi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients
Baruch Brenner, Ravit Geva, Megan Rothney, et al.
The American Journal of Surgical Pathology
|
March 25, 2008
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia, Laura H Tang, Martin R Weiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2020
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD
Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, et al.
Targeted Oncology
|
January 22, 2018
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
Ofer Purim, Alexander Beny, Moshe Inbar, et al.
The Oncologist
|
September 8, 2018
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, et al.
Cancer Research
|
February 6, 2021
Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles
Nil Grunberg, Meirav Pevsner-Fischer, Tal Goshen-Lago, et al.
JAMA Network Open
|
October 19, 2020
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial
Benoist Chibaudel, Julie Henriques, Manel Rakez, et al.
Nature Cancer
|
February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Nancy Gavert, Yaara Zwang, Roi Weiser, et al.
Frontiers in Pharmacology
|
May 6, 2026
Favorable safety outcomes of a perioperative propranolol and etodolac regimen in cancer patients in four randomized controlled trials
Nahida Sakis, Liat Sorski, Eden Asraf, et al.
Page
of 12